PA8456701A1 - Composiciones parenterales de alatrofloxacino - Google Patents

Composiciones parenterales de alatrofloxacino

Info

Publication number
PA8456701A1
PA8456701A1 PA19988456701A PA8456701A PA8456701A1 PA 8456701 A1 PA8456701 A1 PA 8456701A1 PA 19988456701 A PA19988456701 A PA 19988456701A PA 8456701 A PA8456701 A PA 8456701A PA 8456701 A1 PA8456701 A1 PA 8456701A1
Authority
PA
Panama
Prior art keywords
alatrofloxacino
parenteral compositions
mesylate
purifying
procedures
Prior art date
Application number
PA19988456701A
Other languages
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8456701A1 publication Critical patent/PA8456701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A MESILATO DE ALATROFLOXACINO ESENCIALMENTE EXENTO DE IMPUREZAS POCO POLARES, A COMPOSICIONES PARENTERALES DE MESILATO DE ALATROFLOXACINO Y A PROCEDIMIENTOS PARA PURIFICAR MESILATO DE ALATROFLOXACINO.
PA19988456701A 1997-08-01 1998-08-03 Composiciones parenterales de alatrofloxacino PA8456701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
PA8456701A1 true PA8456701A1 (es) 2000-05-24

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988456701A PA8456701A1 (es) 1997-08-01 1998-08-03 Composiciones parenterales de alatrofloxacino

Country Status (40)

Country Link
US (1) US6194429B1 (es)
EP (1) EP1000086B1 (es)
JP (1) JP3463928B2 (es)
KR (1) KR20010022495A (es)
CN (1) CN1265671A (es)
AP (1) AP1031A (es)
AR (1) AR015417A1 (es)
AT (1) ATE259827T1 (es)
AU (1) AU734863B2 (es)
BG (1) BG104105A (es)
BR (1) BR9811580A (es)
CA (1) CA2296466C (es)
CO (1) CO4970688A1 (es)
DE (1) DE69821767T2 (es)
DK (1) DK1000086T3 (es)
DZ (1) DZ2576A1 (es)
EA (1) EA002120B1 (es)
ES (1) ES2214716T3 (es)
GT (1) GT199800112A (es)
HN (1) HN1998000106A (es)
HR (1) HRP980417B1 (es)
HU (1) HUP0004793A3 (es)
ID (1) ID24374A (es)
IL (1) IL134156A0 (es)
IS (1) IS5339A (es)
MA (1) MA24626A1 (es)
NO (1) NO20000485L (es)
NZ (1) NZ502249A (es)
OA (1) OA11281A (es)
PA (1) PA8456701A1 (es)
PE (1) PE103799A1 (es)
PL (1) PL338477A1 (es)
PT (1) PT1000086E (es)
SK (1) SK1012000A3 (es)
TN (1) TNSN98146A1 (es)
TW (1) TW538043B (es)
UY (1) UY25113A1 (es)
WO (1) WO1999006430A1 (es)
YU (1) YU2500A (es)
ZA (1) ZA986874B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
WO2003088897A2 (en) 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
TR201909016T4 (tr) 2012-06-19 2019-07-22 Debiopharm Int Sa (E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
BR112016024841A2 (pt) * 2014-04-25 2017-10-24 Naurex Inc composições estáveis de peptídeos neuroativos
AU2017223037B2 (en) 2016-02-26 2022-04-14 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
BR9408490A (pt) 1994-01-18 1997-08-26 Pfizer Processo e intermediários para a preparação de sais do ácido nafftiridonocarboxílico
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
DK0833837T3 (da) * 1995-06-15 2002-09-02 Pfizer Fremgangsmåde til fremstilling af derivater af azabicyclonaphthydridincarboxylsyre omfattende et dipeptid
RU2151152C1 (ru) 1995-08-29 2000-06-20 Пфайзер Инк. Полиморфы 6-n-(l-ala-l-ala)-тровафлоксацина
KR100343909B1 (ko) 1995-08-29 2003-04-10 화이자 인코포레이티드 트로바플록사신의쯔비터이온형태
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
CA2296466A1 (en) 1999-02-11
NO20000485D0 (no) 2000-01-31
YU2500A (sh) 2002-09-19
PT1000086E (pt) 2004-05-31
EA002120B1 (ru) 2001-12-24
HUP0004793A3 (en) 2001-10-29
AP1031A (en) 2001-12-21
ES2214716T3 (es) 2004-09-16
HRP980417A2 (en) 1999-08-31
UY25113A1 (es) 2000-12-29
CN1265671A (zh) 2000-09-06
KR20010022495A (ko) 2001-03-15
AU734863B2 (en) 2001-06-21
GT199800112A (es) 2000-01-15
HUP0004793A2 (hu) 2001-04-28
HN1998000106A (es) 1999-01-08
ID24374A (id) 2000-07-13
CO4970688A1 (es) 2000-11-07
NZ502249A (en) 2001-11-30
IS5339A (is) 2000-01-14
JP2001512133A (ja) 2001-08-21
WO1999006430A1 (en) 1999-02-11
DE69821767T2 (de) 2005-01-13
TNSN98146A1 (fr) 2005-03-15
EA200000086A1 (ru) 2000-08-28
AP9801310A0 (en) 1998-09-30
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
DE69821767D1 (de) 2004-03-25
MA24626A1 (fr) 1999-04-01
JP3463928B2 (ja) 2003-11-05
OA11281A (en) 2002-11-19
CA2296466C (en) 2003-04-15
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
SK1012000A3 (en) 2000-09-12
ATE259827T1 (de) 2004-03-15
DZ2576A1 (fr) 2003-02-22
NO20000485L (no) 2000-03-27
AR015417A1 (es) 2001-05-02
EP1000086A1 (en) 2000-05-17
DK1000086T3 (da) 2004-05-17
EP1000086B1 (en) 2004-02-18
US6194429B1 (en) 2001-02-27
ZA986874B (en) 2000-01-31
BG104105A (bg) 2000-08-31
BR9811580A (pt) 2000-08-22
HRP980417B1 (en) 2002-10-31
PE103799A1 (es) 1999-10-25

Similar Documents

Publication Publication Date Title
PA8456701A1 (es) Composiciones parenterales de alatrofloxacino
MY115935A (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
FR17C0003I2 (fr) Steroides comme agonistes de fxr
DE69516128D1 (de) Mercaptoacetylamid-1,3,4,5-tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
BR0113286A (pt) Pirazóis substituìdos
ES2188666T3 (es) Analogos de la distamicina utilies como agentes antitumorales o antivirales.
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
ES2173477T3 (es) Derivados de tetrahidronaftaleno y su utilizacion terapeutica.
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
ATE297903T1 (de) Substituierte phenyluracile
SE9801494D0 (sv) Novel use
MXPA03001081A (es) Medicamento anti-inflamatorio.
BR9509608A (pt) Inibidores de proliferação de células de músculo liso
PT1056754E (pt) Derivados fosfatados de 1,3,4-oxadiazolona de diarilo
EA200100297A1 (ru) Моногидрат гидробромида элетриптана
HN1998000102A (es) Composiciones solubilizadas de sertralina
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
ES2188273T3 (es) Farmacos anticarcinogenos a base de antraquinona.
DK1075480T3 (da) Rensning af carboxaldehyd
GB9806409D0 (en) Processes for preparing intermediates
PT1651596E (pt) Novos derivados de 4,4?-ditiobis-(3-aminobutano-1-sulfonatos) e composições que os contêm
BR0214886A (pt) Fenilalquinos
BR9809439A (pt) Processos para preparação de benzotiofenos
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao